Clinicians override around nine in ten drug-interaction alerts. Alert fatigue means the warning that matters gets dismissed along with the many that don't. PolyScope is a patient-aware triage layer for medication alerts. It sits on top of existing interaction checks and reorganizes their output for the specific patient: major alerts stay interruptive, related alerts are grouped into clinical problems, and gaps such as therapeutic duplications are surfaced. No alert is hidden, and every decision is explained, traced and replayable. Built by Catalyst AI Research (Haifa). Patent pending (FR). We are looking for clinical partners (hospitals, HMOs, pharmacists), pilot sites and pre-seed investors. Founder: Frédéric David Blum — AI researcher and engineer, 20+ years in DSP and systems engineering, 2 granted US patents, degrees in mathematics, physics and electrical engineering. Website: https://polyscoperx.com